Community Acquired Pneumonia (CAP) caused by Staphylococcus Aureus Infections

Also known as: Community Acquired Pneumonia (CAP) caused by Staphylococcus aureus Infection

Drug	Drug Name	Drug Description
DB14733	Ceftobiprole medocaril	A broad spectrum 5th-generation cephalosporin antibacterial indicated for certain kinds of pneumonia, bacteremia, and skin and skin structure infections, including those caused by MRSA.
DB00601	Linezolid	An oxazolidinone antibiotic used to treat infections by susceptible strains of aerobic Gram-positive bacteria.

Drug	Drug Name	Target	Type
DB14733	Ceftobiprole medocaril	MecA	target
DB14733	Ceftobiprole medocaril	Penicillin-binding protein 2B	target
DB14733	Ceftobiprole medocaril	Penicillin-binding protein 2X	target
DB14733	Ceftobiprole medocaril	Solute carrier organic anion transporter family member 1B1	transporter
DB14733	Ceftobiprole medocaril	Solute carrier organic anion transporter family member 1B3	transporter
DB14733	Ceftobiprole medocaril	Canalicular multispecific organic anion transporter 1	transporter
DB14733	Ceftobiprole medocaril	Bile salt export pump	transporter
DB00601	Linezolid	23S ribosomal RNA	target
DB00601	Linezolid	Amine oxidase [flavin-containing] A	enzyme
DB00601	Linezolid	Amine oxidase [flavin-containing] B	enzyme
DB00601	Linezolid	Serum albumin	carrier
DB00601	Linezolid	Solute carrier family 22 member 6	transporter
DB00601	Linezolid	Solute carrier family 22 member 8	transporter

Drug	Drug Name	Phase	Status	Count